Possible role of matriptase in the diagnosis of ovarian cancer

被引：20

作者：

Johnson, MD ^{[1
]}

Oberst, MD

Lin, CY

Dickson, RB

机构：

[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Dept Oncol, Washington, DC 20057 USA

[2] NCI, Canc Res Ctr, Cell & Canc Biol Branch, Bethesda, MD 20892 USA

[3] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA

来源：

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 2003年 / 3卷 / 03期

关键词：

diagnosis; HAI-1; matniptase; ovarian cancer; screening;

D O I：

10.1586/14737159.3.3.331

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

There are increasing data that suggest a role for the serine protease matriptase and its inhibitor, hepatocyte growth factor activator inhibitor-1, in the pathogenesis and progression of ovarian cancer. This review will discuss the matriptase/inhibitor system in the context of ovarian cancer and examine the possibility that this system might be a useful therapeutic and/or diagnostic target in this disease.

引用

页码：331 / 338

页数：8

共 69 条

[21] Hepatocyte growth factor scatter factor Met signaling in tumorigenicity and invasion/metastasis [J].

Jeffers, M ;

Rong, S ;

VandeWoude, GF .

JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (09) :505-513

[22]

Kang JY, 2003, CANCER RES, V63, P1101

[23] Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues [J].

Kataoka, H ;

Suganuma, T ;

Shimomura, T ;

Itoh, H ;

Kitamura, N ;

Nabeshima, K ;

Koono, M .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (05) :673-682

[24] The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent [J].

Kennedy, AR .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1406S-1412S

[25] Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains [J].

Kim, MG ;

Chen, C ;

Lyu, MS ;

Cho, EG ;

Park, D ;

Kozak, C ;

Schwartz, RH .

IMMUNOGENETICS, 1999, 49 (05) :420-428

[26] Characterization of a membrane-bound arginine-specific serine protease from rat intestinal mucosa [J].

Kishi, K ;

Yamazaki, K ;

Yasuda, I ;

Yahagi, N ;

Ichinose, M ;

Tsuchiya, Y ;

Athauda, SBP ;

Inoue, H ;

Takahashi, K .

JOURNAL OF BIOCHEMISTRY, 2001, 130 (03) :425-430

[27]

Konecny G, 2001, CLIN CANCER RES, V7, P1743

[28] Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc [J].

Kuhn, W ;

Schmalfeldt, B ;

Reuning, U ;

Pache, L ;

Berger, U ;

Ulm, K ;

Harbeck, N ;

Späthe, K ;

Dettmar, P ;

Höfler, H ;

Jänicke, F ;

Schmitt, M ;

Graeff, H .

BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1746-1751

[29] Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease [J].

Lee, SL ;

Dickson, RB ;

Lin, CY .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36720-36725

[30] Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk [J].

Lin, CY ;

Anders, J ;

Johnson, M ;

Dickson, RB .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18237-18242

← 1 2 3 4 5 6 7 →